Sildenafil Tablet, Film Coated
Product Images NDC 62135-372

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 62135-372). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Sildenafil Tablet 20mg Bottle Label)

Label for Sildenafil Tablets USP 20 mg, film-coated tablets in a package of 90 tablets by Chartwell RX, LLC. The label includes dosage form, strength, prescription status, storage instructions, barcode, and manufacturer information.*

FDA Label Image

Image Description (Sildenafil Tablets Figure 1)

A forest plot illustrating fold changes and 90% confidence intervals in AUC and Cmax of various interacting drugs relative to Sildenafil alone. The graph shows drug names on the y-axis, fold change values on the x-axis, and dosing recommendations such as 'No dose adjustment' or 'Coadministration not recommended.'*

FDA Label Image

Image Description (Sildenafil Tablets Figure 2)

A chart displaying fold change and 90% confidence intervals for pharmacokinetic parameters (INR, AUC, Cmax, BT) of sildenafil when coadministered with various interacting drugs, including Acenocoumarol, Aspirin, Atorvastatin, Bosentan, Doxazosin (1,2,3), Ethinyloestradiol, Levonorgestrel, Phenprocoumon, Ritonavir, Saquinavir, and Tolbutamide. Recommendations for dose adjustment are provided for each drug interaction.*

FDA Label Image

Image Description (Sildenafil Tablets Figure 3)

A vertical bar chart depicting change from baseline (meters) over weeks of study (4, 8, and 12). It compares four groups: Sildenafil 20 mg TID, Sildenafil 40 mg TID, Sildenafil 80 mg TID, and placebo, with data points and error bars shown for each time point across the groups.*

FDA Label Image

Image Description (Sildenafil Tablets Figure 4)

A forest plot chart showing placebo-corrected changes in 6-minute walk distance for Sildenafil 20 mg once daily. It compares multiple subgroups including baseline walk distance, etiology, pulmonary hypertension criteria, gender, age, mean pulmonary arterial pressure, and pulmonary vascular resistance index, presenting confidence intervals and mean differences.*

FDA Label Image

Image Description (Sildenafil Tablets Figure 5)

A line graph showing the percentage of subjects without a clinically worsening event over 112 days from randomization. Two lines compare placebo and Sildenafil, indicating higher percentage maintenance in the Sildenafil group throughout the period.*

FDA Label Image

Image Description (Sildenafil Tablets Structure)

Chemical structure diagram showing the molecular composition of Sildenafil, illustrating its ring structures, functional groups, and chemical bonds as part of the active ingredient in the Sildenafil 20 mg oral tablet by Chartwell RX, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.